"id:ID","label","instanceType","uuid","description","name","text","id"
"758","","OBJECTIVE","36132652-6d5f-4e4c-9647-af957d8719d2","Main objective","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1"
"759","","OBJECTIVE","186e3900-1ef0-4fde-a6f6-26e9281aed20","Safety","OBJ2","To document the safety profile of the xanomeline TTS.","Objective_2"
"760","","OBJECTIVE","1e29f8a6-7c5d-4f9e-ab43-06fc8441cf05","Behaviour","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3"
